Kan Zhu

Company: CSL Seqirus

Job title: Director

Bio:

Kan Zhu is an accomplished analytical scientist and assay developer with over 20 years of experience in the field of drug discovery and development. Throughout his career, Kan has worked in various companies such as Novartis, Vertex, Biogen and CSL. His expertise includes biophysical methods, LCMS, ELISA, ADA, NAb, FACS, imaging etc. His recent work focused on the characterization of LNP and protein using biophysical tools, imaging, LCMS, and cell-based assays for vaccine discovery and development.

Seminars:

Workshop A – Providing a Comprehensive Overview of Core Analytical Methods & Assays for Successful Regulatory Submissions & Batch Release of LNP-Mediated Drugs 8:30 am

Unlock the fundamental and critical analytical strategies behind successful LNP drug development in this hands-on 101 workshop. Gain a clear understanding of essential QC release assays, enabling accurate execution to meet regulatory expectations and confidently drive your LNPs from lab to market. Delving into a regulatory-focused list of required QC release assays for robust regulatory…Read more

day: Pre-Conference Workshop Day

Panel Discussion: Decoding LNP Function Through Advanced Imaging to Enhance Therapeutic Design & Endosomal Escape 11:40 am

How to gain robust and reliable biological conclusions from imaging analysis? How to orthogonally apply imaging methods for accurate characterization of lipid arrangement and link to performance? How does the LNP morphology impact its endosomal escape profile?Read more

day: Conference Day One